There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BeiGene (ONC – Research Report) and Embecta ...

California-based ImmunityBio has entered into a collaboration and supply agreement with Sino-American biotech BeiGene (to be ...

JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...

BeiGene Ltd ( ($HK:6160) ) has issued an announcement. BeiGene Ltd., a biopharmaceutical company, announced the grant of share options and ...

ImmunityBio will part with 10 employees this quarter. Last fall, it cut 31 employees. The moves come as the biotech works to ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the ...

SEC recommends import & marketing permission to Glenmark for tislelizumab injection: Our Bureau, New Delhi Tuesday, February 4, 2025, 08:00 Hrs [IST] The Subject Expert Committee ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

In recent company developments, MAIA Biotechnology, Inc., a pharmaceutical preparations company valued at $54.93 million, has ...

BeiGene has said it intends to resubmit the drug for use by NHS Scotland. The recommendations come 10 months after Brukinsa was approved by the Medicines and Healthcare products Regulatory Agency ...